BRIEF-Insys Therapeutics says enrollment of first patient in phase II trial for treatment of cocaine dependence

* Insys therapeutics announces first patient enrolled in

phase ii trial for the treatment of cocaine dependence using

pharmaceutical cannabidiol

Source text for Eikon:

Further company coverage:

Read more